AQR Capital Management »

Aeglea Biotherapeutics shares owned by AQR Capital Management

Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by AQR Capital Management from 13F filings

Historical chart of AQR Capital Management investment in Aeglea Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aeglea Biotherapeutics held by AQR Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeglea Biotherapeutics by AQR Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $286k 17k 16.76
2025-06-30 $269k 18k 14.97
2024-09-30 $1.0M 35k 29.50

More positions owned by AQR Capital Management

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Broadcom (AVGO)
Roblox Corp Cl A (RBLX)
Meta Platforms Cl A (META)
Wal-Mart Stores (WMT)
Alphabet Cap Stk Cl A (GOOGL)
Verisign (VRSN)
Alphabet Cap Stk Cl C (GOOG)
Adobe Systems Incorporated (ADBE)
Arista Networks Com Shs (ANET)
Palantir Technologies Cl A (PLTR)
PNC Financial Services (PNC)

View all positions for AQR Capital Management

Top funds holding Aeglea Biotherapeutics

FMR
Fairmount Funds Management
BlackRock
Rtw Investments
Tang Capital Management
Vanguard Group
VR Adviser
Braidwell
Capital Research and Management Company - Division 3
Driehaus Capital Management
Commodore Capital
State Street Corporation
Wellington Management Company
Paradigm Biocapital Advisors
Affinity Asset Advisors

View all funds holding Aeglea Biotherapeutics